Jalra Trio Tab

JALRA TRIO TAB

JALRA TRIO TAB is a combination medication manufactured by USV PRIVATE LIMITED, designed for the comprehensive management of Type 2 Diabetes Mellitus. This triple therapy aids in controlling high blood sugar levels when diet and exercise alone are insufficient.

Composition Each tablet of JALRA TRIO typically contains:

• Vildagliptin: 100 mg
• Metformin: 500 mg
• Dapagliflozin: 10 mg

Uses JALRA TRIO TAB is prescribed for adults with Type 2 Diabetes Mellitus to:

• Control and lower high blood sugar levels.
• Improve glycemic control.
• Enhance insulin sensitivity and reduce glucose production in the liver.
• Increase glucose excretion through urine.
• Reduce the risk of heart failure and kidney complications associated with diabetes.
• Support weight loss and improve metabolic parameters in overweight or obese diabetic patients.

Dosage and Administration The dosage of JALRA TRIO TAB is determined by a healthcare provider based on individual patient needs, blood glucose levels, and other medications being taken. It is typically administered orally, once or twice daily, preferably with meals to minimize gastrointestinal side effects. Tablets should be swallowed whole and not crushed or chewed. Consistent daily timing is recommended for optimal results.

Side Effects Common side effects may include:

• Diarrhea
• Nausea and Vomiting
• Headache
• Hypoglycemia (low blood sugar), especially when taken with other antidiabetic medicines or alcohol.
• Increased urination or frequent urination
• Genital mycotic infections (vaginal yeast infection, inflammation of the penis in men)
• Abdominal pain

Serious side effects, though less common, can include:

• Lactic acidosis (symptoms: fast, shallow breathing, severe stomach pain, vomiting, muscle cramps)
• Pancreatitis
• Allergic reactions
• Liver or kidney problems
• Vitamin B12 deficiency

Precautions

• Pregnancy and Breastfeeding: Not generally recommended during pregnancy or breastfeeding; consult a doctor.
• Alcohol: Limit alcohol consumption as it can affect blood sugar control and increase the risk of hypoglycemia and lactic acidosis.
• Kidney/Liver Problems: Use with caution in patients with kidney problems (risk of lactic acidosis) or liver disease, and regular monitoring is essential.
• Drug Interactions: Inform your doctor about all medications, supplements, and herbal products being taken due to potential interactions affecting blood sugar or kidney function (e.g., beta-blockers, diuretics).
• Children: Not recommended for use in children under 18 years of age.
• Elderly Patients: May be more sensitive to side effects; dosing adjustments may be required.
• Avoid abruptly stopping the medication as it can lead to complications.

Storage Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children. Do not use beyond the expiration date. The recommended storage temperature is typically below 30°C or between 10°C to 25°C.

JALRA TRIO TAB is a combination medicine prescribed for the management of type 2 diabetes mellitus. It contains three active ingredients: Vildagliptin, Metformin, and Glimepiride, which work together to help control blood sugar levels.

Here are some frequently asked questions about JALRA TRIO TAB:

1. What is JALRA TRIO TAB used for?

JALRA TRIO TAB is used to treat adults with type 2 diabetes mellitus to help control high blood sugar levels. It is typically prescribed when diet and exercise alone are not enough, or when other antidiabetic medications haven't sufficiently managed blood sugar. It helps lower both fasting and after-meal blood glucose levels.

2. How does JALRA TRIO TAB work?

JALRA TRIO TAB combines three different medicines:

• Vildagliptin increases the production of incretin hormones, which stimulate the pancreas to release more insulin when blood sugar levels are high and reduce glucagon production (a hormone that raises blood sugar).
• Metformin primarily works by reducing the amount of glucose produced by the liver, decreasing glucose absorption from the intestines, and improving the body's sensitivity to insulin.
• Glimepiride stimulates the pancreas to release more insulin, helping to lower blood glucose levels. This multi-pronged approach helps achieve comprehensive blood sugar control.

3. What is the usual dosage for JALRA TRIO TAB?

The dosage of JALRA TRIO TAB is determined by your doctor based on your individual condition, blood sugar levels, and response to treatment. It is usually taken orally once or twice daily, preferably with meals, to help reduce gastrointestinal side effects and optimize absorption. It's crucial to follow your doctor's instructions precisely and not to adjust the dosage yourself.

4. What are the possible side effects of JALRA TRIO TAB?

Common side effects can include gastrointestinal upset such as nausea, vomiting, diarrhea, abdominal pain, loss of appetite, and a metallic taste. Other possible side effects may include headache and hypoglycemia (low blood sugar), especially when taken with other antidiabetic medications or without adequate food intake. Less common but serious side effects can include lactic acidosis, particularly in patients with kidney problems, liver disease, or excessive alcohol consumption.

5. Is JALRA TRIO TAB safe during pregnancy or breastfeeding?

JALRA TRIO TAB is generally not recommended during pregnancy or breastfeeding. Limited human data suggest that the drug components may pass into breast milk and could potentially harm the baby. If you are pregnant, planning to become pregnant, or breastfeeding, you should consult your doctor before taking this medication, as they will weigh the benefits against potential risks.

6. Can JALRA TRIO TAB be taken with other medications?

JALRA TRIO TAB can interact with several other medications. It's important to inform your doctor about all medicines you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins. Specific interactions can occur with:

• Other diabetic medications (e.g., insulin, sulfonylureas) which may increase the risk of hypoglycemia.
• Diuretics (water pills) which can lead to excessive water loss.
• Iodinated contrast agents used in certain imaging procedures, as they may increase the risk of acute kidney failure and lactic acidosis.
• Certain asthma medications, birth control pills, thyroid medicines, corticosteroids, and anti-epileptic drugs.

7. What precautions should be taken while using JALRA TRIO TAB?

You should use JALRA TRIO TAB with caution if you have kidney or liver problems, heart problems, or a history of pancreatitis. Regular monitoring of blood sugar levels is essential. Avoid excessive alcohol consumption, as it can affect blood sugar control and increase the risk of side effects like hypoglycemia and lactic acidosis. JALRA TRIO TAB is not for use in Type 1 diabetes or diabetic ketoacidosis. Dizziness or drowsiness can occur, so exercise caution when driving or operating machinery.

8. What happens if a dose of JALRA TRIO TAB is missed?

If you miss a dose of JALRA TRIO TAB, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one, as this can lead to dangerously low blood sugar levels.

9. How should JALRA TRIO TAB be stored?

JALRA TRIO TAB should be stored in a cool, dry place, away from direct sunlight and moisture. It should be kept out of the sight and reach of children and pets. Do not use the medication beyond its expiration date.